Jubilant Pharmova Ltd.

NSE: JUBLPHARMA | BSE: 530019 | ISIN: INE700A01033 | Industry: Pharmaceuticals
| Strong Performer, Under Radar
1194.5000 -8.10 (-0.67%)
NSE Jul 16, 2025 15:31 PM
Volume: 115.1K
 

logo
Jubilant Pharmova Ltd.
31 Oct 2017
1194.50
-0.67%
buy
by ICICI Securities Limited
Target: 815
ICICI Securities Limited
ICICI Securities Ltd | Retail Equity Research Revenues grew 19% YoY to | 1642 crore (I-direct estimate: | 1716 crore). Revenues in the pharma segment grew 12% YoY to | 905 crore (I-direct estimate: | 934 crore) while life science ingredients (LSI) revenues grew 21% YoY to | 739 crore (I-direct estimate: | 755...
 
Jubilant Pharmova Ltd. has gained 29.85% in the last 3 Months
More from Jubilant Pharmova Ltd.
Recommended
Market closes flat, ITC Hotels' Q1FY26 net profit beats Forecaster estimates by 35.5%
Trendlyne Marketwatch | 16 Jul 2025, 03:59PM
Five stocks to buy from analysts this week - July 15, 2025
The Baseline | 15 Jul 2025, 06:44PM
Earnings Call Transcript - Q4FY20 for Jubilant Life Sciences
| 30 May 2020